可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Nakagami H, Morishita R, Yamamoto K, et al. Antiapoptotic action of hepatocyte growth factor through mitogenactivated protein kinase on human aortic endothelial cells[J]. J Hypertens,2000,18:1411-1420.
[2]Yo Y, Morishita R, Yamamoto K, et al. Hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease[ J]. Kindey Int, 1998,53:50.
[3]Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhusis in rats[ J]. Nature Med, 1999,5:226.
[4]余国龙,梁晓秋,谢秀梅,等. 高血压大鼠心脏肥厚过程中心肌细胞凋亡心肌纤维化动态观察[ J]. 高血压杂志,2001,9(4):322-325.
[5]Smith CT, Sun D, Hoeglar C, et al. Reduced gene expression of vascular endothelial NO synthase and cycloxygenase1 in heart fiailure[J]. Cir Res, 1996,78:58-64.
[6]Hayakawa H, Raij L. The link among nitric oxide synthase activity, endothelial function and aortic and ventricular hypertrophy in hypertension[ J]. Hypertens,1997,29(part 2):235-241.
[7]Taniyama Y, Morishita R, Aoki M, et al. Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy[J]. Hypertension,2002, 40(1):47-53.
[8]Li Y,Takemura G,Kosai K, et al. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice[J]. Circulation,2003,107(19):2499-2506.